Julie Perrin
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Chronic Lymphocytic Leukemia Research, Immunodeficiency and Autoimmune Disorders, COVID-19 Clinical Research Studies, COVID-19 and healthcare impacts
Most-Cited Works
- → Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study(2019)104 cited
- → Longitudinally Extensive Myelitis Associated With Immune Checkpoint Inhibitors(2021)59 cited
- → Anti–programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study(2021)46 cited
- → Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies(2022)38 cited
- → Respiratory Distress in SARS-CoV-2 without Lung Damage: Phrenic Paralysis Should Be Considered in COVID-19 Infection(2020)31 cited
- → Severe anti-PD1-related meningoencephalomyelitis successfully treated with anti-integrin alpha4 therapy(2021)20 cited
- → Cutaneous metastasis revealing a relapse of gastric linitis(2012)10 cited
- → Lung involvement and clinical characteristics in anti-MDA5 positive connective tissue diseases(2018)2 cited
- → Coatomer-associated protein subunit alpha syndrome: abnormal trafficking between the Golgi complex and the endoplasmic reticulum(2020)2 cited
- → Impact de la BPCO : du handicap aux exacerbations(2014)1 cited